Displaying drugs 10151 - 10175 of 10948 in total
Bosakitug
Bosakitug (BSI-045B) is under investigation in clinical trial NCT05932654 (POC Study to Evaluate BSI-045B Monotherapy and BSI-045B Add-on Therapy With Dupilumab in Atopic Dermatitis).
Investigational
Matched Description: … 045B Monotherapy and BSI-045B Add-on Therapy With Dupilumab in Atopic Dermatitis). ... Bosakitug (BSI-045B) is under investigation in clinical trial NCT05932654 (POC Study to Evaluate BSI- …
Navarixin
Navarixin has been investigated for the treatment of Asthma.
Investigational
Matched Description: … Navarixin has been investigated for the treatment of Asthma. …
Vestipitant
Vestipitant has been investigated for the treatment of Tinnitus.
Investigational
Matched Description: … Vestipitant has been investigated for the treatment of Tinnitus. …
GW-870086
GW870086X has been investigated for the treatment of ASTHMA.
Investigational
Matched Description: … GW870086X has been investigated for the treatment of ASTHMA. …
Modufolin
Modufolin is under investigation for the treatment of Osteosarcoma.
Investigational
Matched Description: … Modufolin is under investigation for the treatment of Osteosarcoma. …
Veldoreotide
Somatoprim is under investigation for the treatment of Acromegaly.
Investigational
Matched Description: … Somatoprim is under investigation for the treatment of Acromegaly. …
Ferric oxyhydroxide
An antiferromagnetic material; constitutes the core of natural ferritin.
Experimental
Matched Description: … An antiferromagnetic material; constitutes the core of natural ferritin. …
Pimelic Acid
A group of compounds that are derivatives of heptanedioic acid with the general formula R-C7H11O4. [PubChem]
Experimental
Matched Description: … A group of compounds that are derivatives of heptanedioic acid with the general formula R-C7H11O4. …
IDM-1
IDM-1 is IDM’s most advanced antibody-based Cell drug for the treatment of cancer. It is comprised of MAK(Monocytes-derived Activated Killer) cells associated with MDX-210, a bispecific anti-HER-2/neu antibody developed by Medarex Inc.
Investigational
Matched Description: … IDM-1 is IDM’s most advanced antibody-based Cell drug for the treatment of cancer. ... It is comprised of MAK(Monocytes-derived Activated Killer) cells associated with MDX-210, a bispecific …
Vinylglycine
Vinylglycine is an irreversible inhibitor of aspartate aminotransferase.
Experimental
Matched Description: … Vinylglycine is an irreversible inhibitor of aspartate aminotransferase. …
Sacubitrilat
A metabolite of LCZ696 with neprilysin inhibitory activity.
Experimental
Matched Description: … A metabolite of LCZ696 with neprilysin inhibitory activity. …
Onvansertib
Onvansertib is under investigation in clinical trial NCT03303339 (Onvansertib in Combination With Either Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).).
Investigational
Matched Description: … Onvansertib is under investigation in clinical trial NCT03303339 (Onvansertib in Combination With Either ... Low-dose Cytarabine or Decitabine in Adult Patients With Acute Myeloid Leukemia (AML).). …
Golvatinib
Golvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck.
Investigational
Matched Description: … Golvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the …
ISP-001
ISP-001 consists of sleeping beauty transposon-engineered autologous plasmablasts for expression and delivery of alpha-L-iduronidase.
Investigational
Matched Description: … delivery of alpha-L-iduronidase. ... ISP-001 consists of sleeping beauty transposon-engineered autologous plasmablasts for expression and …
Prosetin
Prosetin is an orally administered blocker of MAP4K under investigation for the treatment of amyotrophic lateral sclerosis.
Investigational
Matched Description: … Prosetin is an orally administered blocker of MAP4K under investigation for the treatment of amyotrophic …
Dasotraline
Dasotraline is a serotonin, norepinephrine and dopamine reuptake inhibitor (SNDRI) that is under investigation for the treatment of Binge Eating Disorder, Adult Attention Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder, and Adult Attention Deficit Hyperactivity Disorder.
Investigational
Matched Description: … norepinephrine and dopamine reuptake inhibitor (SNDRI) that is under investigation for the treatment of …
CX516
Investigational
Helium He-3
Helium He-3 is under investigation in clinical trial NCT00846014 (Asthma Exacerbation and Helium-3 MRI).
Investigational
Matched Description: … Helium He-3 is under investigation in clinical trial NCT00846014 (Asthma Exacerbation and Helium-3 MRI …
GLPG-0259
GLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability and Food Effect).
Investigational
Matched Description: … GLPG-0259 is under investigation in clinical trial NCT01024517 (GLPG0259 Solid Formulation Bioavailability …
MCMV5322A
MCMV5322A is an anticytomegalovirus monoclonal IgG1 antibody used in combination with MCMV3068A to form RG7667.
Investigational
Matched Description: … MCMV5322A is an anticytomegalovirus monoclonal IgG1 antibody used in combination with [MCMV3068A] to …
Veverimer
Veverimer is under investigation in clinical trial NCT03390842 (Long-term Safety Extension to Study TRCA-301).
Investigational
Matched Description: … Veverimer is under investigation in clinical trial NCT03390842 (Long-term Safety Extension to Study TRCA …
Ensovibep
Ensovibep is under investigation in clinical trial NCT04501978 (ACTIV-3: Therapeutics for Inpatients With COVID-19).
Investigational
Matched Description: … Ensovibep is under investigation in clinical trial NCT04501978 (ACTIV-3: Therapeutics for Inpatients …
5'-Guanosine-Diphosphate-Monothiophosphate
Guanosine 5'-(trihydrogen diphosphate), monoanhydride with phosphorothioic acid. A stable GTP analog which enjoys a variety of physiological actions such as stimulation of guanine nucleotide-binding proteins, phosphoinositide hydrolysis, cyclic AMP accumulation, and activation of specific proto-oncogenes.
Experimental
Matched Description: … A stable GTP analog which enjoys a variety of physiological actions such as stimulation of guanine nucleotide-binding ... proteins, phosphoinositide hydrolysis, cyclic AMP accumulation, and activation of specific proto-oncogenes …
Licogliflozin
Licogliflozin is under investigation in clinical trial NCT03320941 (A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity).
Investigational
Matched Description: … the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity). ... Licogliflozin is under investigation in clinical trial NCT03320941 (A Dose-finding Study to Evaluate …
Islatravir
Islatravir is under investigation in clinical trial NCT04233216 (Doravirine/islatravir (DOR/ISL) in Heavily Treatment-experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)).
Investigational
Matched Description: … Islatravir is under investigation in clinical trial NCT04233216 (Doravirine/islatravir (DOR/ISL) in Heavily …
Displaying drugs 10151 - 10175 of 10948 in total